Canada markets closed

ARS Pharmaceuticals, Inc. (SPRY)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
9.75+0.29 (+3.07%)
At close: 04:00PM EDT
9.79 +0.04 (+0.41%)
After hours: 04:50PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 944.72M
Enterprise Value 716.63M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)30.94k
Price/Book (mrq)4.09
Enterprise Value/Revenue 23.89k
Enterprise Value/EBITDA -10.61

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 357.40%
S&P500 52-Week Change 322.38%
52 Week High 311.27
52 Week Low 32.55
50-Day Moving Average 38.94
200-Day Moving Average 36.44

Share Statistics

Avg Vol (3 month) 3732.4k
Avg Vol (10 day) 3516.82k
Shares Outstanding 596.89M
Implied Shares Outstanding 696.89M
Float 837.14M
% Held by Insiders 127.67%
% Held by Institutions 165.26%
Shares Short (Apr 15, 2024) 46.09M
Short Ratio (Apr 15, 2024) 46.57
Short % of Float (Apr 15, 2024) 411.92%
Short % of Shares Outstanding (Apr 15, 2024) 46.30%
Shares Short (prior month Mar 15, 2024) 44.25M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-225,066.67%

Management Effectiveness

Return on Assets (ttm)-16.40%
Return on Equity (ttm)-21.59%

Income Statement

Revenue (ttm)30k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -67.45M
Net Income Avi to Common (ttm)-54.37M
Diluted EPS (ttm)-0.57
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)228.36M
Total Cash Per Share (mrq)2.37
Total Debt (mrq)274k
Total Debt/Equity (mrq)0.12%
Current Ratio (mrq)96.92
Book Value Per Share (mrq)2.39

Cash Flow Statement

Operating Cash Flow (ttm)-59.27M
Levered Free Cash Flow (ttm)-36.17M